References
- Suzumiya J., Ohshima K., Takeshita M., Kanda M., Kawasaki C., Kimura N., Tamura K., Kikuvhi M. Nasal lymphoma in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene. Leukemia and Lymphoma 1999; 35: 567–578
- Shiramizu B., Barriga F., Neequaye J., Jafri A., Dalla-Favera R., Neri A., Guttierez M., Levine P., Magrath I. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516–1526
- Kenneth Lucas G., Karen Pollok E., David Emanuel J. Posttransplant EBV induced Lymphoproliferative Disorders. Leukemia and Lymphoma 1996; 25: 1–8
- Bai X., Hosier G., Rogers B. B., Dawson D. B., Scheuermann R. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clinical Chemistry 1997; 43: 1843–1849
- Limaye A. P., Huang M. L., Atienza E. E., Ferrenberg J. M., Corey L. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders. Journal of Clinical Microbiology 1999; 37: 1113–1116
- Lo Y. M., Chan L. Y., Lo K. W., Leung S. F., Zhang J., Chan A. T., Lee J. C., Hjelm N. M., Johnson P. J., Huang D. P. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Research 1999; 59: 1188–1191
- Mutiangura A., Pornthanakasem W., Theamboonlers A., Sriuranpong V., Lertsanguansinchi P., Yenrudi S., Voravud N., Supiyaphun P., Poovorawan Y. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clinical Cancer Research 1998; 4: 665–669
- Heid C. A., Stevens J., Livak K. J., Williams P. M. Real time quantitative PCR. Genome-Research 1996; 10: 986–994
- Kimura H., Morita M., Yabuta Y., Kuzushima K., Kato K., Kojima S., Matsuyama T., Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. Journal of Clinical Microbiology 1999; 37: 132–136
- Kreuzer K. A., Lass U., Landt O., Nitsche A., Laser J., Ellerbrok H., Pauli G., Huhn D., Schmidt C. A. Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clinical Chemistry 1999; 45: 297–300
- Yamamoto M., Kimura H., Hironaka T., Hirai K., Hasegawa S., Kuzushima K., Shibata M., Morishima T. Detection and quantitation of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. Journal of Clinical Microbiology 1995; 33: 1765–1768
- Magrath I., Jain V., Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Seminar in Cancer Biology 1992; 3: 285–295